Boundless Bio, Inc. (BOLD) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of Boundless Bio, Inc. and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — BOLD vs ONCY
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)ONCY -42.0% (-16.6%/yr)ONCY compounded faster over this window
BOLD ONCY
BOLD vs ONCY: by the numbers
- •ONCY is the larger company ($60M vs $58M market cap).
Metrics side by side
Valuation
| Metric | BOLD | ONCY |
|---|---|---|
| P/B ratio | 0.87 | N/A |
Profitability
| Metric | BOLD | ONCY |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -58.99% | N/A |
| ROIC | -43.97% | -1235.48% |
Growth (annualized)
| Metric | BOLD | ONCY |
|---|---|---|
| Total return CAGR (5Y) | N/A | -21.00% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.